NCT01198834

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 600 (actual)
• Sponsor: MEDRx USA, Inc. · Industry
• Sex: All
• Age: 14 Years
• Healthy volunteers: Not accepted

Summary

A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

Conditions

• Ankle Sprains

Interventions

Type	Name	Description
DRUG	MRX-7EAT	Application of up to two patches at the discretion of the investigator for up to 7 days.
DRUG	Placebo	Application of up to two patches at the discretion of the investigator for up to 7 days.
DRUG	Lidocaine	Application of up to two patches at the discretion of the investigator for up to 7 days.
DRUG	Etodolac	Application of up to two patches at the discretion of the investigator for up to 7 days.

Timeline

• Start date: 2010-09-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2010-09-10
• Last updated: 2018-01-17

Locations

33 sites across 1 country: United States